CASEY ZIEGLER: Open Payments
NPI 1730849712 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,964 in 31 payments from 11 companies in 2025. Trend: 2023 $169 · 2024 $1,054 · 2025 $2,964
Travel & lodging: $1,862Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $1,504 |
| Curonix LLC | 6 | $814 |
| Stryker Corporation | 1 | $156 |
| Collegium Pharmaceutical, Inc. | 5 | $98 |
| TerSera Therapeutics LLC | 3 | $90 |
| Tonix Medicines, Inc. | 1 | $84 |
| Averitas Pharma Inc. | 3 | $74 |
| MML US, Inc. | 1 | $54 |
| Medtronic, Inc. | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
Products named: Intracept, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, MULTIGEN 2, Prialt, QUTENZA, Belbuca, ReActiv8, INCEPTIV.
Industry payments across FL — which companies pay providers there.
